Shandong Xinhua Pharmaceutical Company Limited (000756.SZ)
000756.SZ Stock Price Chart
Explore Shandong Xinhua Pharmaceutical Company Limited interactive price chart. Choose custom timeframes to analyze 000756.SZ price movements and trends.
000756.SZ Company Profile
Discover essential business fundamentals and corporate details for Shandong Xinhua Pharmaceutical Company Limited (000756.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
6 Aug 1997
Employees
7.30K
Website
https://www.xhzy.comCEO
Tongqing He
Description
Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. It operates through Chemical bulk drugs, Preparations, and Chemical intermediates and Others segments. The company offers active pharmaceutical ingredients, pharmaceutical preparations, and chemical products, such as antipyretic analgesics; drugs for cardiovascular and cerebrovascular diseases; anti-infectives; drugs for diseases related to the central nervous system; and other drugs under the Xinhua brand. It also provides prepared Chinese herbal medicine decoction, traditional Chinese medicines, chemical preparations, antibiotics, biochemical medicines, chemical bulk drugs, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc.; and chemical raw materials, such as dimethyl sulfate, isobutylbenzene, 1,8-diazabicyclo, undec-7-ene, and tetramethylguanidine. In addition, the company offers materials and intermediates, powders for injection and tablets; tablets, hard capsules, granules, and dry suspension; imports and exports goods and technologies; designs medical projects; and health products research and development activities. Further, it engages in the certification business; electrical equipment engineering; and installation and testing of chemical equipment and electrical equipment, as well as the sale of mechanical, hardware, and electrical equipment. Additionally, the company produces and sells high-end steroid system APIs and intermediates; and provides internet data, internet sells, and internet information services for pharmaceuticals and medical devices, etc. It operates in the People's Republic of China, the Americas, Europe, and internationally. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.
000756.SZ Financial Timeline
Browse a chronological timeline of Shandong Xinhua Pharmaceutical Company Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 26 Aug 2025
EPS came in at ¥0.17 matching the estimated ¥0.17.
Dividend declared on 18 Jul 2025
A dividend of ¥0.25 per share was announced, adjusted to ¥0.25. The dividend was paid on 18 Jul 2025.
Earnings released on 28 Apr 2025
EPS came in at ¥0.15 falling short of the estimated ¥0.18 by -16.67%, while revenue for the quarter reached ¥2.43B .
Earnings released on 28 Mar 2025
EPS came in at ¥0.18 falling short of the estimated ¥0.27 by -31.63%, while revenue for the quarter reached ¥1.73B .
Earnings released on 29 Oct 2024
EPS came in at ¥0.12 , while revenue for the quarter reached ¥2.00B .
Dividend declared on 27 Sept 2024
A dividend of ¥0.03 per share was announced, adjusted to ¥0.03. The dividend was paid on 27 Sept 2024.
Earnings released on 22 Aug 2024
EPS came in at ¥0.17 , while revenue for the quarter reached ¥2.24B , missing expectations by -57.01%.
Dividend declared on 30 Jul 2024
A dividend of ¥0.25 per share was announced, adjusted to ¥0.25. The dividend was paid on 30 Jul 2024.
Earnings released on 25 Apr 2024
EPS came in at ¥0.21 , while revenue for the quarter reached ¥2.47B , missing expectations by -52.49%.
Earnings released on 28 Mar 2024
EPS came in at ¥0.16 , while revenue for the quarter reached ¥1.59B , missing expectations by -69.48%.
Earnings released on 27 Oct 2023
EPS came in at ¥0.18 , while revenue for the quarter reached ¥1.83B , missing expectations by -64.96%.
Earnings released on 24 Aug 2023
EPS came in at ¥0.17 , while revenue for the quarter reached ¥2.03B , missing expectations by -60.98%.
Dividend declared on 26 Jul 2023
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 26 Jul 2023.
Earnings released on 20 Apr 2023
EPS came in at ¥0.22 , while revenue for the quarter reached ¥2.64B , missing expectations by -49.33%.
Earnings released on 24 Mar 2023
EPS came in at ¥0.17 , while revenue for the quarter reached ¥2.05B .
Earnings released on 30 Sept 2022
EPS came in at ¥0.16 , while revenue for the quarter reached ¥1.79B .
Dividend declared on 5 Aug 2022
A dividend of ¥0.15 per share was announced, adjusted to ¥0.15. The dividend was paid on 5 Aug 2022.
Earnings released on 30 Jun 2022
EPS came in at ¥0.13 , while revenue for the quarter reached ¥1.83B .
Earnings released on 8 Apr 2022
EPS came in at ¥0.17 , while revenue for the quarter reached ¥1.83B .
Earnings released on 31 Dec 2021
EPS came in at ¥0.10 , while revenue for the quarter reached ¥1.62B .
Earnings released on 22 Oct 2021
EPS came in at ¥0.16 , while revenue for the quarter reached ¥1.78B .
Earnings released on 30 Sept 2021
EPS came in at ¥0.14 , while revenue for the quarter reached ¥1.39B .
Dividend declared on 30 Jul 2021
A dividend of ¥0.15 per share was announced, adjusted to ¥0.15. The dividend was paid on 30 Jul 2021.
Earnings released on 31 Mar 2021
EPS came in at ¥0.16 , while revenue for the quarter reached ¥1.77B .
Earnings released on 31 Dec 2020
EPS came in at ¥0.13 , while revenue for the quarter reached ¥1.37B .
Earnings released on 30 Sept 2020
EPS came in at ¥0.12 , while revenue for the quarter reached ¥1.35B .
000756.SZ Stock Performance
Access detailed 000756.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.